RHK.DU RHOEN-KLINIKUM

Other Metals & Mining Dusseldorf Exchange
- EUR
Market cap
-
P/E
22.7x
P/B
0.72x
ROE
3.3%
Dividend yield
0.83%
Fundamental score
2.0/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is RHK.DU undervalued?

Graham number

The Graham number of RHOEN-KLINIKUM cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RHOEN-KLINIKUM fundamental analysis

10 of 22 checks passed

ROE 0/2

Low return on equity (3.3%), below 10%.

ROA 0/1

Return on assets (2.4%) is below the industry median (3.8%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-20.5%) is not above the 5-year average (88.4% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-20.5%) is below the industry median (7.9%).

Revenue Growth 1/2

Revenue grew 5.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 21.8x against interest expense, well covered.

PE vs Market 0/1

PE (22.7x) is above the market median (18.2x).

PE vs Industry 0/1

PE (22.7x) is above the industry median (18.3x).

PBV 1/1

Price to book (0.7x) is below the industry median (2.0x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 16.3, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.26, growth is cheap.

Dividend Yield 0/2

Dividend yield (0.7%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 19.4%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

RHOEN-KLINIKUM stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RHOEN-KLINIKUM

There is no Profile data available for RHK.DU.

Full company profile